Cite

HARVARD Citation

    Bolli, E. et al. (2018). A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo. Oncoimmunology. p. . [Online]. 
  
Back to record